International Small-Cap Fund Shines in Q2 with Significant Outperformance
Finance

International Small-Cap Fund Shines in Q2 with Significant Outperformance

authorBy Mariana Mazzucato
DateAug 26, 2026
Read time2 min

In the second quarter of the fiscal year, the International Growth Fund - Investor Class delivered an impressive performance, recording a 17.60% return. This significantly surpassed its benchmark, the MSCI AC (All Country) World ex USA Small Cap Index, which saw a return of 9.62% during the same period. This notable outperformance was largely attributed to astute stock-picking within the United Kingdom, Japan, and Germany. The fund's strategic investments in these regions proved to be highly effective, contributing substantially to its overall success.

International Growth Fund Excels in Second Quarter with Strong Returns

The second quarter of the year saw a noteworthy triumph for the International Growth Fund - Investor Class. This investment vehicle reported an exceptional return of 17.60%, substantially eclipsing the 9.62% gain posted by its comparative index, the MSCI AC World ex USA Small Cap Index. The core drivers behind this strong performance were meticulously chosen equities in several key international markets. Specifically, the fund's holdings in companies located in the United Kingdom, Japan, and Germany played a pivotal role in boosting its results. These strategic allocations highlight the fund manager's proficiency in navigating complex global landscapes and identifying high-potential opportunities within the small-cap sector. The fund's management team comprises seasoned professionals, including Ken Applegate, CFA, CMT, serving as the Lead Portfolio Manager with a decade of experience on the fund and twelve years at Wasatch. He is supported by Derrick Tzau, CFA, the Associate Portfolio Manager, who brings six years of fund experience and eight years at Wasatch.

This exemplary performance by the International Growth Fund - Investor Class underscores the critical importance of diligent research and strategic asset allocation in achieving superior investment outcomes. The focused approach on specific geographical markets, coupled with an emphasis on small-cap companies, proved to be a winning formula in the second quarter. Investors may glean valuable insights from this fund's success, particularly regarding the potential for outperformance when active management effectively targets growth opportunities in international markets. This quarter's results serve as a compelling case study for the benefits of expert-driven portfolio construction.

More Articles
Finance
Constellation Energy: A Reliable Dividend Growth Stock
Constellation Energy (CEG), an electric utility company, is demonstrating consistent dividend growth since its spin-off from Exelon in 2022. The company has nearly tripled its annual payout between 2022 and 2025 and plans a 10% dividend hike this year. With a diversified energy portfolio including natural gas, nuclear, and renewables, CEG is also well-positioned to capitalize on the growing demand for AI power.
By Strive MasiyiwaAug 26, 2026
Finance
Clover Health's AI-Powered Future: A Deep Dive into Growth and Valuation
Clover Health, a prominent health insurance provider, leverages its innovative AI-powered Clover Assistant to significantly reduce claims costs and enhance member profitability. This article explores the company's financial outlook, including baseline and bullish DCF valuations that suggest a notable upside from its current share price. Key growth drivers, potential Medicare Advantage bonuses, and strategic recommendations are also discussed, painting a comprehensive picture of CLOV's investment potential.
By Michele FerreroAug 26, 2026
Finance
James Hardie's Robust Performance and Strategic Growth Outlook
James Hardie (JHX) recently reported impressive earnings, exceeding expectations and raising future guidance. This strong performance is largely attributed to the strategic acquisition of AZEK and efficient operational execution. Despite a significant 64.5% year-over-year revenue increase to $1.48 billion, organic growth was approximately 12%, accompanied by a 230 basis point rise in adjusted EBITDA margin. Management aims to reduce net leverage below 2x by Q2 2028, supported by strong cash flow and a planned $980 million sale of its European business. While the company demonstrates solid expansion and financial health, a neutral stance is maintained to observe integration success and market conditions.
By Fareed ZakariaAug 26, 2026
Finance
Olin Corporation: A Resilient Investment Amidst Chemical Sector Challenges
Despite recent operational setbacks and broader industry headwinds that led to a 12% share price drop, Olin Corporation (OLN) presents a compelling long-term investment. Its Q2 performance, although impacted by an outage and weak demand, showcased the strength of its epoxy and ammunition divisions. The forthcoming merger with Huntsman is expected to unlock significant cost synergies and bolster Olin's financial health, offering investors a robust free cash flow yield and a secure dividend.
By David RubensteinAug 26, 2026
Finance
Tilly's: A Cautious Buy on Turnaround Hopes
Tilly's (TLYS) is rated as a conditional Buy, pending positive Q2 FY2026 results. The company has shown recent improvements, including a 22.9% rise in Q1 comparable sales and nine consecutive months of positive comps. A DCF analysis suggests a $6.02 per share valuation. However, high fixed lease commitments and sales relapse risks necessitate careful position sizing. Investors should monitor future earnings for sustained positive trends and inventory management before increasing exposure.
By Fareed ZakariaAug 26, 2026